NPS PHARMACEUTICALS, INC.

Inactive Instrument

NPS Pharmaceuticals, Inc. Stock

Stocks

US62936P1030

Biotechnology & Medical Research

End-of-day quote Nasdaq Other stock markets
- ^USD	-

15-02-12	NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval	RE
15-01-26	NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase	RE

on all subscriptions*

Enjoy this offer

* See conditions under "Our services"

Latest news : NPS Pharmaceuticals, Inc.

15-02-12	NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval	RE
15-01-26	NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase	RE
15-01-14	Aegerion Pharmaceuticals : Exclusive: Top investors push Aegerion to oust CEO, consider sale - sources	RE
15-01-12	Alcoa : Wall St. falls; energy shares dragged down further by oil	RE
14-12-17	AbbVie : Shire considering bid for NPS Pharmaceuticals - Bloomberg	RE
14-06-01	NPS Pharmaceuticals : Shire secures $5 billion funding for NPS Pharma bid - The Times	RE

Press Releases: NPS Pharmaceuticals, Inc.

15-02-21	NPS Pharmaceuticals : Shire Completes Acquisition of NPS Pharma	PR
15-02-06	NPS Pharmaceuticals : Biotech Stocks Review - Arena Pharma, Amgen, NPS Pharma, ZIOPHARM Oncology, and Advaxis	PR
15-01-27	NPS PHARMACEUTICALS : INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of NPS Pharmaceuticals, Inc. (NPSP) Over the Proposed Sale of the Company to Shire PLC	BU
15-01-23	NPS Pharmaceuticals : FDA Approves Natpara® (parathyroid hormone) for Injection as an Adjunct to Calcium and Vitamin D to Control Hypocalcemia in Patients with Hypoparathyroidism	BU
15-01-16	NPS Pharmaceuticals : SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of NPS Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information	BU

More press releases

News in other languages: NPS Pharmaceuticals, Inc.

15-02-12	Shire : Hausse du résultat du T4, le titre monte
15-01-26	American Airlines : Les valeurs à suivre sur les marchés américains
15-01-26	USA-Les valeurs à suivre à Wall Street
15-01-12	Foundation Medicine : Wall Street clôture en baisse avec le pétrole
15-01-12	Wall Street finit en baisse avec le pétrole

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ARGENX SE	+0.03%	+0.45%	+57.61%	+108.72%	54.92B
	WUXI APPTEC CO., LTD.	-0.34%	+3.51%	+45.55%	+40.16%	44.31B
	BIONTECH SE	+0.29%	+6.20%	-14.80%	-19.65%	22.96B
	INSMED INCORPORATED	-0.40%	+3.49%	-1.29%	+387.06%	21.12B
	WUXI BIOLOGICS (CAYMAN) INC.	-2.91%	+0.27%	+13.28%	-36.73%	16.31B
	GENMAB A/S	-1.40%	-2.27%	+6.75%	-41.20%	15.19B
	EXELIXIS, INC.	-0.24%	+2.44%	+27.43%	+177.49%	13.32B
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+1.48%	+9.81%	+19.29%	-	12.48B
	PHARMAESSENTIA CORPORATION	+0.32%	+2.81%	+96.37%	+213.49%	11.21B
	Average	-0.36%	+2.75%	+27.80%	+103.67%	23.54B
	Weighted average by Cap.	-0.31%	+2.86%	+32.20%	+95.35%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrows Top Investments!

SEIZE THE OFFER!